Statements (56)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Planned_Parenthood
|
| gptkbp:administered_by |
gptkb:patches
medical supervision applying to skin |
| gptkbp:approves |
gptkb:FDA
|
| gptkbp:available_on |
gptkb:patches
|
| gptkbp:can_be_combined_with |
gptkb:ethinyl_estradiol
|
| gptkbp:casnumber |
50742-69-1
|
| gptkbp:chemical_formula |
C22 H28 N2 O3
|
| gptkbp:contraindication |
liver disease
pregnancy |
| gptkbp:control_system |
hormonal levels
|
| gptkbp:developed_by |
progesterone
|
| https://www.w3.org/2000/01/rdf-schema#label |
norelgestromin
|
| gptkbp:is_administered_once |
weekly
|
| gptkbp:is_associated_with |
increased risk of blood clots
|
| gptkbp:is_available_in |
gptkb:various_countries
|
| gptkbp:is_available_in_forms_of |
transdermal delivery system
|
| gptkbp:is_considered |
safe for most women
a contraceptive agent a synthetic progestin effective for contraception |
| gptkbp:is_effective_against |
up to 7 days
STIs |
| gptkbp:is_part_of |
contraceptive methods
contraceptive options combination hormonal contraceptive contraceptive healthcare contraceptive patch contraceptive patch system hormonal contraceptive methods hormonal contraceptive regimen |
| gptkbp:is_protected_by |
gptkb:ovulation
unintended pregnancy |
| gptkbp:is_regulated_by |
gptkb:menstrual_cycle
|
| gptkbp:is_related_to |
gptkb:ethinyl_estradiol
|
| gptkbp:is_removed_after |
7 days
|
| gptkbp:is_used_for |
hormonal imbalances
acne menstrual regulation |
| gptkbp:is_used_in |
reproductive health
family planning birth control hormonal therapy menstrual management |
| gptkbp:management |
menstrual symptoms
|
| gptkbp:marketed_as |
the brand name Ortho Evra
|
| gptkbp:metabolism |
liver
|
| gptkbp:side_effect |
headache
nausea breast tenderness |
| gptkbp:storage |
room temperature
|
| gptkbp:suitable_for |
certain cancers
smokers over 35 |
| gptkbp:bfsParent |
gptkb:Ortho_Evra
|
| gptkbp:bfsLayer |
6
|